National Institute of Environmental Health Sciences; Notice of Closed Meeting, 2703-2704 [07-243]
Download as PDF
Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
National Institute of Arthritis and
Musculoskeletal and Skin Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIAMS.
Date: February 8–9, 2007.
Time: 1 p.m. to 1:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 4C32, Bethesda, MD 20892.
Contact Person: John J. O’Shea, MD, PhD,
Scientific Director, National Institute of
Arthritis & Musculoskeletal, and Skin
Diseases, Building 10, Room 9N228, MSC
1820, Bethesda, MD 20892, (301) 496–2612,
osheaj@arb.niams.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, ZEB1 OSR–D M1
Training Grants Review.
Date: February 27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Hotel Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: John Hayes, Scientific
Review Administrator, 6707 Democracy
Blvd., Suite 959, Democracy Two, Bethesda,
MD 20892, (301) 451–3398,
hayesj@mail.nih.gov.
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–242 Filed 1–19–07; 8:45 am]
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for type 1
diabetes. The outcome of the evaluation
will be a decision whether NIDDK
should support the request and make
available contract resources for
development of the potential
therapeutic to improve the treatment or
prevent the development of type 1
diabetes and its complications. The
research proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the proposed research
projects, the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Type 1 Diabetes—
Rapid Access to Intervention Development
Special Emphasis Panel; National Institute of
Diabetes and Digestive and Kidney Diseases.
Date: January 23, 2007.
Time: 3 p.m. to 4 p.m.
Agenda: To evaluate requests for
preclinical development resources for
potential new therapeutics for type 1 diabetes
and its complications.
Place: 6707 Democracy Boulevard,
Bethesda, MD 20892, (Telephone Conference
Call).
Contact Person: Dr. Myrlene Staten, Senior
Advisor, Diabetes Transplation Research,
Division of Diabetes, Endocrinology and
Metabolic Diseases, NIDDK, NIH, 6707
Democracy Boulevard, Bethesda, MD 20892–
5460, 301 402–7886.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 98.849, Kidney Diseases, urology
and Hematology Research, National Institutes
of Health, HHS)
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
rmajette on PROD1PC67 with NOTICES
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–235 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
15:20 Jan 19, 2007
Jkt 211001
2703
National Institutes of Health
Dated: January 12, 2007.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–238 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIAMS.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel, Development of an ELISA
for Measuring Serum Levels.
Date: February 8, 2007.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
E:\FR\FM\22JAN1.SGM
22JAN1
2704
Federal Register / Vol. 72, No. 13 / Monday, January 22, 2007 / Notices
Place: NIEHS/National Institutes of Health,
Building 4401, East Campus, 79 T.W.
Alexander Drive, Research Triangle Park, NC
27709, (Telephone Conference Call).
Contact Person: RoseAnne M. McGee,
Associate Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research and Training, Nat.
Institute of Environmental Health Sciences,
P.O. Box 12233, MD EC–30, Research
Triangle Park, NC 27709, (919) 541–0752,
mcgee1@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93,894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–243 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
rmajette on PROD1PC67 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 07–27, Review R21s.
Date: February 21, 2007.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lynn M King, PhD.,
Scientific Review Administrator, Scientific
VerDate Aug<31>2005
15:20 Jan 19, 2007
Jkt 211001
Review Branch, 45 Center Dr., Rm 4AN–32F,
National Inst of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402, 301–594–5006,
lynn.king@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 07–30, Review R21s.
Date: March 8, 2007.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lynn M King, PhD.,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., Rm 4AN–32F,
National Inst of Dental & Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892–6402, 301–594–5006,
lynn.king@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 07–31, Review R03s, R21s.
Date: March 9, 2007.
Time: 8:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Mary Kelly, Scientific
Review Specialist, National Institute of
Dental & Craniofacial Res., 45 Center Drive,
Natcher Bldg., RM 4AN38J, Bethesda, MD
20892–6402, (301) 594–4809,
marylkelly@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 07–32, Review R21s.
Date: March 9, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Mary Kelly, Scientific
Review Specialist, National Institute of
Dental & Craniofacial Res., 45 Center Drive,
Natcher Bldg., RM 4AN38J, Bethesda, MD
20892–6402, (301) 594–4809,
mary.kelly@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–248 Filed 1–19–07; 8:45am]
BILLING CODE 4140–01–M
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings:
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Prevention and Management
of Dengue Virus.
Date: January 19, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIAID. 6700B Rockledge Drive,
Room 3200, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Mini Paulose-Murphy,
PhD, Scientific Review Administrator,
Scientific Review Program, Division of
Extramural Activities, National Institutes of
Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, 301–451–
2640, murphym@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Viral Immunology.
Date: January 31, 2007.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Michelle M Timmerman,
PhD, Scientific Review Administrator,
Scientific Review Program, NIAID/NIH/
DHHS, Room 3258, 6700B Rockledge Drive,
MSC–7616, Bethesda, MD 20892–7616, 301–
451–4573, timmermanm@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Non-Human Primate Islet/
Kidney Transportation Tolerance.
E:\FR\FM\22JAN1.SGM
22JAN1
Agencies
[Federal Register Volume 72, Number 13 (Monday, January 22, 2007)]
[Notices]
[Pages 2703-2704]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-243]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Environmental Health Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Environmental Health
Sciences Special Emphasis Panel, Development of an ELISA for
Measuring Serum Levels.
Date: February 8, 2007.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract proposals.
[[Page 2704]]
Place: NIEHS/National Institutes of Health, Building 4401, East
Campus, 79 T.W. Alexander Drive, Research Triangle Park, NC 27709,
(Telephone Conference Call).
Contact Person: RoseAnne M. McGee, Associate Scientific Review
Administrator, Scientific Review Branch, Division of Extramural
Research and Training, Nat. Institute of Environmental Health
Sciences, P.O. Box 12233, MD EC-30, Research Triangle Park, NC
27709, (919) 541-0752, mcgee1@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.115,
Biometry and Risk Estimation--Health Risks from Environmental
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic
Research and Education; 93,894, Resources and Manpower Development
in the Environmental Health Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114, Applied Toxicological Research
and Testing, National Institutes of Health, HHS)
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-243 Filed 1-19-07; 8:45 am]
BILLING CODE 4140-01-M